Cargando…
Evaluation of Sex Differences in Preclinical Pharmacology Research: How Far Is Left to Go?
Until the last quarter of the 20th century, sex was not recognized as a variable in health research, nor was it believed to be a factor that could affect health and illness. Researchers preferred studying male models for a variety of reasons, such as simplicity, lower costs, hormone confounding effe...
Autores principales: | Allegra, Sarah, Chiara, Francesco, Di Grazia, Daniela, Gaspari, Marco, De Francia, Silvia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10300853/ https://www.ncbi.nlm.nih.gov/pubmed/37375734 http://dx.doi.org/10.3390/ph16060786 |
Ejemplares similares
-
Milestones in Heart Failure: How Far We Have Come and How Far We Have Left to Go
por: Gajjela, Harini, et al.
Publicado: (2021) -
How far can we go in precision with ALR?
por: Blondel, A
Publicado: (1990) -
Simplified TAVR Procedure: How Far Is It Possible to Go?
por: Leclercq, Florence, et al.
Publicado: (2022) -
Biologics: how far can they go in Crohn’s disease?
por: Dunleavy, Katie A, et al.
Publicado: (2022) -
Elagolix: How far can it go in the world of gynecology?
por: Danis, Rachel B.
Publicado: (2023)